{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:39:10Z","timestamp":1791898750202,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1038\/ncpneuro0261","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T08:07:53Z","timestamp":1153901273000},"page":"437-447","source":"Crossref","is-referenced-by-count":177,"title":["Sporadic inclusion body myositis\u2014diagnosis, pathogenesis and therapeutic strategies"],"prefix":"10.1038","volume":"2","author":[{"given":"Marinos C","family":"Dalakas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpneuro0261_CR1","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325: 1487\u20131498","journal-title":"N Engl J Med"},{"key":"BFncpneuro0261_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1055\/s-2008-1041132","volume":"13","author":"EA Sekul","year":"1993","unstructured":"Sekul EA and Dalakas MC (1993) Inclusion body myositis: new concepts. Semin Neurol 13: 256\u2013263","journal-title":"Semin Neurol"},{"key":"BFncpneuro0261_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs RC  et al. (1995) Inclusion body myositis and myopathies. Ann Neurol 38: 705\u2013713","journal-title":"Ann Neurol"},{"key":"BFncpneuro0261_CR4","first-page":"1367","volume-title":"Myology","author":"J Mikol","year":"2004","unstructured":"Mikol J and Engel AG (2004) Inclusion body myositis. In Myology, edn 2, 1367\u20131388 (Eds Engel AG and Franzini-Armstrong C) New York: McGraw\u2013Hill"},{"key":"BFncpneuro0261_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/00002281-200311000-00009","volume":"15","author":"V Askanas","year":"2003","unstructured":"Askanas V and Engel WK (2003) Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging. Curr Opin Rheumatol 15: 737\u2013744","journal-title":"Curr Opin Rheumatol"},{"key":"BFncpneuro0261_CR6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I","volume":"23","author":"BA Phillips","year":"2000","unstructured":"Phillips BA  et al. (2000) Prevalence of sporadic inclusion body myositis in Western Australia. Muscle Nerve 23: 970\u2013972","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0261_CR7","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/WNL.55.9.1385","volume":"55","author":"UA Badrising","year":"2000","unstructured":"Badrising UA  et al. (2000) Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 55: 1385\u20131387","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1212\/WNL.48.1.29","volume":"48","author":"CA Luciano","year":"1997","unstructured":"Luciano CA and Dalakas MC (1997) Inclusion body myositis: no evidence for a neurogenic component. Neurology 48: 29\u201333","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.55.2.296","volume":"55","author":"A Peng","year":"2000","unstructured":"Peng A  et al. (2000) Disease progression in sporadic inclusion body myositis: observations in 78 patients. Neurology 55: 296\u2013298","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1212\/WNL.48.4.863","volume":"48","author":"EA Sekul","year":"1997","unstructured":"Sekul EA  et al. (1997) Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis. Neurology 48: 863\u2013866","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR11","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archneur.1991.00530240033013","volume":"48","author":"JR Mendell","year":"1991","unstructured":"Mendell JR  et al. (1991) Amyloid filaments in inclusion body myositis: novel findings provide insight into nature of filaments. Arch Neurol 48: 1229\u20131234","journal-title":"Arch Neurol"},{"key":"BFncpneuro0261_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/brain\/awh052","volume":"127","author":"D Selcen","year":"2004","unstructured":"Selcen D  et al. (2004) Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain 127: 439\u2013451","journal-title":"Brain"},{"key":"BFncpneuro0261_CR13","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0046-8177(98)90425-7","volume":"29","author":"C Semino-Mora","year":"1988","unstructured":"Semino-Mora C and Dalakas MC (1988) Rimmed vacuoles with \u03b2-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (post-poliomyelitis muscular atrophy): similarities with inclusion body myositis. Human Pathol 29: 1128\u20131133","journal-title":"Human Pathol"},{"key":"BFncpneuro0261_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ana.410400407","volume":"40","author":"AA Amato","year":"1996","unstructured":"Amato AA  et al. (1996) Inclusion body myositis: clinical and pathological boundaries. Ann Neurol 40: 581\u2013586","journal-title":"Ann Neurol"},{"key":"BFncpneuro0261_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0165-5728(97)00245-2","volume":"84","author":"BM Koffman","year":"1998","unstructured":"Koffman BM  et al. (1998) HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 84: 139\u2013142","journal-title":"J Neuroimmunol"},{"key":"BFncpneuro0261_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1399-0039.2004.00310.x","volume":"64","author":"P Price","year":"2004","unstructured":"Price P  et al. (2004) Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. Tissue Antigens 64: 575\u2013580","journal-title":"Tissue Antigens"},{"key":"BFncpneuro0261_CR17","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","volume":"63","author":"UA Badrising","year":"2004","unstructured":"Badrising UA  et al. (2004) Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology 63: 2396\u20132398","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR18","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/ana.410380619","volume":"38","author":"MJ Garlepp","year":"1995","unstructured":"Garlepp MJ  et al. (1995) Apolipoprotein E epsilon 4 in inclusion body myositis. Ann Neurol 38: 957\u2013959","journal-title":"Ann Neurol"},{"key":"BFncpneuro0261_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1212\/WNL.55.8.1235","volume":"55","author":"M Orth","year":"2000","unstructured":"Orth M  et al. (2000) Sporadic inclusion body myositis not linked to prion protein codon 129 methionine homozygosity. Neurology 55: 1235","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/brain\/120.4.653","volume":"120","author":"K Sivakumar","year":"1997","unstructured":"Sivakumar K  et al. (1997) An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis: studies in three families. Brain 120: 653\u2013661","journal-title":"Brain"},{"key":"BFncpneuro0261_CR21","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1212\/WNL.47.4.977","volume":"47","author":"K Sivakumar","year":"1996","unstructured":"Sivakumar K and Dalakas MC (1996) The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews. Neurology 47: 977\u2013984","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/ng718","volume":"29","author":"I Eisenberg","year":"2001","unstructured":"Eisenberg I  et al. (2001) The UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 29: 83\u201387","journal-title":"Nat Genet"},{"key":"BFncpneuro0261_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","volume":"21","author":"BM Koffman","year":"1998","unstructured":"Koffman BM  et al. (1998) Autoimmune diseases and autoantibodies associated with sporadic inclusion body myositis. Muscle Nerve 21: 115\u2013117","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0261_CR24","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/ana.410370615","volume":"37","author":"MC Dalakas","year":"1995","unstructured":"Dalakas MC and Illa I (1995) Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells. Ann Neurol 37: 806\u2013810","journal-title":"Ann Neurol"},{"key":"BFncpneuro0261_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ana.410410116","volume":"41","author":"MC Dalakas","year":"1997","unstructured":"Dalakas MC  et al. (1997) Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations. Ann Neurol 41: 100\u2013104","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"BFncpneuro0261_CR26","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1212\/01.wnl.0000192129.65677.87","volume":"66","author":"MC Dalakas","year":"2006","unstructured":"Dalakas MC (2006) Inflammatory, immune and viral aspects of inclusion-body myositis. Neurology 66 (Suppl): S33\u2013S38","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR27","first-page":"948","volume":"158","author":"MC Dalakas","year":"2002","unstructured":"Dalakas MC (2002) Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects. Rev Neurol (Paris) 158: 948\u2013958","journal-title":"Rev Neurol"},{"key":"BFncpneuro0261_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.410230111","volume":"23","author":"G Karpati","year":"1988","unstructured":"Karpati G  et al. (1988) Expression of immunoreactive major histocapability complex products in human skeletal muscles. Ann Neurol 23: 64\u201372","journal-title":"Ann Neurol"},{"key":"BFncpneuro0261_CR29","first-page":"1142","volume":"143","author":"D Michaelis","year":"1993","unstructured":"Michaelis D  et al. (1993) Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am J Pathol 143: 1142\u20131149","journal-title":"Am J Pathol"},{"key":"BFncpneuro0261_CR30","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","volume":"97","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju K  et al. (2000) Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 97: 9209\u20139214","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0261_CR31","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/brain\/awh148","volume":"127","author":"J Schmidt","year":"2004","unstructured":"Schmidt J  et al. (2004) Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Brain 127: 1182\u20131190","journal-title":"Brain"},{"key":"BFncpneuro0261_CR32","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1172\/JCI118749","volume":"97","author":"N Goebels","year":"1996","unstructured":"Goebels N  et al. (1996) Differential expression of perforin in muscle-infiltrating T cell in polymyositis and dermatomyositis. J Clin Invest 97: 2905","journal-title":"J Clin Invest"},{"key":"BFncpneuro0261_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.it.2005.05.003","volume":"26","author":"H Wiendl","year":"2005","unstructured":"Wiendl H  et al. (2005) Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol 26: 373\u2013380","journal-title":"Trends Immunol"},{"key":"BFncpneuro0261_CR34","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/brain\/120.6.929","volume":"120","author":"L Behrens","year":"1997","unstructured":"Behrens L  et al. (1997) Cytotoxic mechanisms in inflammatory myopathies: co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells. Brain 120: 929","journal-title":"Brain"},{"key":"BFncpneuro0261_CR35","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/00005072-199612000-00003","volume":"55","author":"C Schneider","year":"1996","unstructured":"Schneider C  et al. (1996) MHC class I mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol 55: 1205\u20131209","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0261_CR36","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1001\/archneur.55.12.1509","volume":"55","author":"MC Dalakas","year":"1998","unstructured":"Dalakas MC (1998) Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol 55: 1509\u20131512","journal-title":"Arch Neurol"},{"key":"BFncpneuro0261_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0165-5728(97)00246-4","volume":"84","author":"A Bender","year":"1998","unstructured":"Bender A  et al. (1998) T-cell heterogeneity in muscle lesions of inclusion body myositis. J Neuroimmunol 84: 86\u201391","journal-title":"J Neuroimmunol"},{"key":"BFncpneuro0261_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-3083.2003.01251.x","volume":"58","author":"K Muntzing","year":"2003","unstructured":"Muntzing K  et al. (2003) Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time. Scand J Immunol 58: 195\u2013200","journal-title":"Scand J Immunol"},{"key":"BFncpneuro0261_CR39","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/brain\/123.10.2030","volume":"123","author":"K Amemiya","year":"2000","unstructured":"Amemiya K  et al. (2000) Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time:studies in repeated muscle biopsies. Brain 123: 2030\u20132039","journal-title":"Brain"},{"key":"BFncpneuro0261_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0002-9440(10)65141-3","volume":"155","author":"K Murata","year":"1999","unstructured":"Murata K and Dalakas MC (1999) Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNA in inflammatory myopathies. Am J Pathol 155: 453\u2013460","journal-title":"Am J Pathol"},{"key":"BFncpneuro0261_CR41","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/brain\/awg114","volume":"126","author":"H Wiendel","year":"2003","unstructured":"Wiendel H  et al. (2003) Muscle fibers and cultured muscle or cells express the B7.1\/2 related costimulatory molecule ICOSL: implications for the pathogenesis of inflammatory myopathies. Brain 126: 1026\u20131035","journal-title":"Brain"},{"key":"BFncpneuro0261_CR42","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/mus.10462","volume":"28","author":"D Figarella-Branger","year":"2003","unstructured":"Figarella-Branger D  et al. (2003) Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 28: 659\u2013682","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0261_CR43","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","volume":"58","author":"JL De Bleecker","year":"2002","unstructured":"De Bleecker JL  et al. (2002) Differential expression of chemokines in inflammatory myopathies. Neurology 58: 1779\u20131785","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0165-5728(03)00218-2","volume":"141","author":"R Raju","year":"2003","unstructured":"Raju R  et al. (2003) Expression of interferon-gamma inducible chemokines in the muscles of patients with inclusion body myositis. J Neuroimmunol 141: 125\u2013131","journal-title":"J Neuroimmunol"},{"key":"BFncpneuro0261_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1212\/WNL.54.1.65","volume":"54","author":"YC Choi","year":"2000","unstructured":"Choi YC and Dalakas MC (2000) Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 54: 65\u201371","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR46","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/brain\/119.6.1887","volume":"119","author":"EJ Cupler","year":"1996","unstructured":"Cupler EJ  et al. (1996) Inclusion body myositis in HIV-I and HTLV-I infected patients. Brain 119: 1887\u20131893","journal-title":"Brain"},{"key":"BFncpneuro0261_CR47","doi-asserted-by":"publisher","first-page":"10320","DOI":"10.1128\/JVI.78.19.10320-10327.2004","volume":"78","author":"S Ozden","year":"2004","unstructured":"Ozden S  et al. (2004) Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia\/lymphoma virus type 1-infected patient with sporadic inclusion body myositis. J Virol 78: 10320\u201310327","journal-title":"J Virol"},{"key":"BFncpneuro0261_CR48","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1086\/344315","volume":"186","author":"M Saito","year":"2002","unstructured":"Saito M  et al. (2002) Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis 186: 1231\u20131241","journal-title":"J Infect Dis"},{"key":"BFncpneuro0261_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1750-3639.2005.tb00504.x","volume":"15","author":"I Ferrer","year":"2005","unstructured":"Ferrer I  et al. (2005) Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis. Brain Pathol 15: 101\u2013108","journal-title":"Brain Pathol"},{"key":"BFncpneuro0261_CR50","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K  et al. (2005) Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 52: 1824\u20131835","journal-title":"Arthritis Rheum"},{"key":"BFncpneuro0261_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S1471-4906(01)01861-0","volume":"22","author":"AG Grandea 3rd","year":"2001","unstructured":"Grandea AG 3rd and Van Kaer L (2001) Tapasin: an ER chaperone that controls MHC class I assembly with peptide. Trends Immunol 22: 194\u2013199","journal-title":"Trends Immunol"},{"key":"BFncpneuro0261_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coi.2003.11.012","volume":"16","author":"PJ Lehner","year":"2004","unstructured":"Lehner PJ and Cresswell P (2004) Recent developments in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 16: 82\u201389","journal-title":"Curr Opin Immunol"},{"key":"BFncpneuro0261_CR53","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/jnen\/63.5.484","volume":"63","author":"I Ferrer","year":"2004","unstructured":"Ferrer I  et al. (2004) Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol 63: 484\u2013498","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncpneuro0261_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9440(10)63089-1","volume":"164","author":"G Vattemi","year":"2004","unstructured":"Vattemi G  et al. (2004) Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 164: 1\u20137","journal-title":"Am J Pathol"},{"key":"BFncpneuro0261_CR55","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1212\/WNL.54.5.1033","volume":"54","author":"BL Banwell","year":"2000","unstructured":"Banwell BL and Engel AG (2000) \u03b1B-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 54: 1033\u20131041","journal-title":"Neurology"},{"issue":"Suppl 1","key":"BFncpneuro0261_CR56","first-page":"A331","volume":"64","author":"J Schmidt","year":"2005","unstructured":"Schmidt J  et al. (2005) Distinct interplay between inflammatory and degeneration-associated molecules in sporadic IBM. Neurology 64 (Suppl 1): A331\u2013A338","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR57","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1126\/science.1126766","volume":"312","author":"T Wileman","year":"2006","unstructured":"Wileman T (2006) Aggresomes and autophagy generate sites for virus replication. Science 312: 875\u2013878","journal-title":"Science"},{"key":"BFncpneuro0261_CR58","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0002-9440(10)62994-X","volume":"167","author":"P Fratta","year":"2005","unstructured":"Fratta P  et al. (2005) Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers. Am J Pathol 167: 517\u2013526","journal-title":"Am J Pathol"},{"key":"BFncpneuro0261_CR59","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1212\/WNL.57.5.755","volume":"57","author":"SA Greenberg","year":"2001","unstructured":"Greenberg SA (2001) DNA microarray gene expression analysis technology and its application to neurological disorders. Neurology 57: 755\u2013761","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR60","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/brain\/awh518","volume":"128","author":"R Raju","year":"2005","unstructured":"Raju R and Dalakas MC (2005) Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biologic validation of clinical relevant genes. Brain 128: 1887\u20131896","journal-title":"Brain"},{"key":"BFncpneuro0261_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/s-2003-41136","volume":"23","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC (2003) Therapeutic approaches in patients with inflammatory myopathies. Semin Neurol 23: 199\u2013206","journal-title":"Semin Neurol"},{"key":"BFncpneuro0261_CR62","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1212\/01.WNL.0000071852.27182.C7","volume":"61","author":"C Lindberg","year":"2003","unstructured":"Lindberg C  et al. (2003) Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study. Neurology 61: 260\u2013262","journal-title":"Neurology"},{"key":"BFncpneuro0261_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ncprheum0140","volume":"2","author":"MC Dalakas","year":"2006","unstructured":"Dalakas MC (2006) Mechanisms of Disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol 2: 219\u2013227","journal-title":"Nat Clin Pract Rheumatol"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0261","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpneuro0261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:27:11Z","timestamp":1684441631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["BFncpneuro0261"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0261","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}